{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:38:45Z","timestamp":1787647125223,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>With the growing availability of RNA sequencing technology in the pathology laboratory, new gene fusion-associated malignancies are increasingly being characterized. In this article, we describe the second ever reported case of a uterine sarcoma harboring a <jats:italic toggle=\"yes\">FGFR1-TACC1<\/jats:italic> gene fusion. The patient, a 53-yr-old perimenopausal woman, was found to have a 6\u2009cm mass spanning the lower uterine segment and endocervix. Histologically, this was a spindle cell neoplasm with coagulative necrosis, moderate cytologic atypia, and increased mitotic activity. By immunohistochemistry, the neoplastic cells coexpressed CD34 and S100, and lacked smooth muscle marker expression. RNA sequencing revealed the presence of a <jats:italic toggle=\"yes\">FGFR1-TACC1<\/jats:italic> gene fusion. This report provides further evidence to suggest that <jats:italic toggle=\"yes\">FGFR1-TACC1<\/jats:italic> may be a recurrent fusion in a subset of uterine sarcomas. RNA sequencing using a panel that includes <jats:italic toggle=\"yes\">FGFR-TACC<\/jats:italic> family fusions should be considered for uterine sarcomas that do not fit conventional diagnostic criteria, particularly as tumors with these fusions may be amenable to targeted therapy.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000846","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T18:02:06Z","timestamp":1638468126000},"page":"588-592","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Uterine Sarcoma With FGFR1-TACC1 Gene Fusion: A Case Report and Review of the Literature"],"prefix":"10.1097","volume":"41","author":[{"given":"Roman E.","family":"Zyla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulisa","family":"Turashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.22846","article-title":"Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria","volume":"59","author":"Antonescu","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","article-title":"NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma","volume":"42","author":"Chiang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/PAS.0000000000001644","article-title":"Neurofibrosarcoma revisited: an institutional case series of uterine sarcomas harboring kinase-related fusions with report of a novel FGFR1-TACC1 fusion","volume":"45","author":"Devereaux","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.1220834","article-title":"Transforming fusions of FGFR and TACC genes in human glioblastoma","volume":"337","author":"Singh","year":"2012","journal-title":"Science"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12967-016-1075-6","article-title":"FGFR1 and NTRK3 actionable alterations in \u201cWild-Type\u201d gastrointestinal stromal tumors","volume":"14","author":"Shi","year":"2016","journal-title":"J Transl Med"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00401-018-1882-3","article-title":"FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma","volume":"136","author":"Sievers","year":"2018","journal-title":"Acta Neuropathol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00401-016-1539-z","article-title":"Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology","volume":"131","author":"Qaddoumi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnen\/nlaa122","article-title":"Spinal cord pilocytic astrocytoma with FGFR1-TACC1 fusion and anaplastic transformation","volume":"80","author":"Daoud","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00401-019-02097-7","article-title":"Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutation","volume":"139","author":"Sievers","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"e28805","DOI":"10.1002\/pbc.28805","article-title":"A novel finding in pediatric leiomyosarcoma: Expanding spectrum of FGFR rearrangements in childhood cancers","volume":"68","author":"Persaud","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250802","first-page":"475","article-title":"FGFR-TACC gene fusions in human glioma","volume":"19","author":"Lasorella","year":"2017","journal-title":"Neuro Oncol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.21037\/tlcr-20-186","article-title":"Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy","volume":"9","author":"Suda","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.4297","article-title":"Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours","volume":"232","author":"Parker","year":"2014","journal-title":"J Pathol"},{"key":"R14-20250802","first-page":"2","article-title":"Enrichment of FGFR3-TACC3 fusions in patients with bladder cancer who are young, Asian, or have never smoked","author":"Nassar","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/annonc\/mdw550","article-title":"Identification of a FGFR3-TACC3 fusion in esophageal cancer","volume":"28","author":"Mizukami","year":"2017","journal-title":"Ann Oncol"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4161\/15384047.2014.961874","article-title":"Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma","volume":"15","author":"Yuan","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"168","DOI":"10.23838\/pfm.2017.00170","article-title":"Identification of FGFR3-TACC3 gene fusion in metastatic gastric cancer","volume":"1","author":"Kim","year":"2017","journal-title":"Precis Future Med"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"a002089","DOI":"10.1101\/mcs.a002089","article-title":"Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer","volume":"4","author":"Dhami","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gore.2015.06.005","article-title":"FGFR3\u2013TACC3: a novel gene fusion in cervical cancer","volume":"13","author":"Carneiro","year":"2015","journal-title":"Gynecol Oncol Rep"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41389-017-0018-2","article-title":"Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions","volume":"7","author":"Tamura","year":"2018","journal-title":"Oncogenesis"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"100668","DOI":"10.1016\/j.gore.2020.100668","article-title":"Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix","volume":"34","author":"Gill","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.3390\/ijms21186856","article-title":"FGFR fusions in cancer: from diagnostic approaches to therapeutic intervention","volume":"21","author":"De Luca","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature25171","article-title":"A metabolic function of FGFR3-TACC3 gene fusions in cancer","volume":"553","author":"Frattini","year":"2018","journal-title":"Nature"},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jtho.2018.09.014","article-title":"Detection of known and novel FGFR fusions in non\u2013small cell lung cancer by comprehensive genomic profiling","volume":"14","author":"Qin","year":"2019","journal-title":"J Thorac Oncol"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","article-title":"The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing","volume":"22","author":"Helsten","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"55924","DOI":"10.18632\/oncotarget.10482","article-title":"FGFR3-TACC3 fusion in solid tumors: mini review","volume":"7","author":"Costa","year":"2016","journal-title":"Oncotarget"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41571-018-0115-y","article-title":"Fibroblast growth factor receptors as treatment targets in clinical oncology","volume":"16","author":"Katoh","year":"2019","journal-title":"Nat Rev Clin Oncol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:03:20Z","timestamp":1754161400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000846","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}